Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
BACKGROUND: MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneously expressed on the merozoite surface and targeted by...
Main Authors: | Gilles Bang, Eric Prieur, Christian Roussilhon, Pierre Druilhe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3228738?pdf=render |
Similar Items
-
The malaria candidate vaccine liver stage antigen-3 is highly conserved in <it>Plasmodium falciparum </it>isolates from diverse geographical areas
by: Druilhe Pierre, et al.
Published: (2009-10-01) -
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720.
by: James S McCarthy, et al.
Published: (2011-01-01) -
Blood-Stage Malaria Vaccines : MSP1 19
by: Chakrit Hirunpetcharat
Published: (2015-02-01) -
MSP1 antibody specificity and malaria vaccine design
by: Curd, Rachel Dawn
Published: (2008) -
Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
by: Vinay Menon, et al.
Published: (2018-01-01)